THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 91 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $70,815,000 | +6.6% | 2,221,302 | +21.2% | 0.01% | -7.1% |
| Q3 2016 | $66,431,000 | +64.0% | 1,833,096 | +2.7% | 0.01% | +55.6% |
| Q2 2016 | $40,518,000 | +37.5% | 1,785,707 | +13.9% | 0.01% | +28.6% |
| Q1 2016 | $29,471,000 | +13.5% | 1,567,595 | -1.0% | 0.01% | +16.7% |
| Q4 2015 | $25,960,000 | +47.5% | 1,583,902 | -1.1% | 0.01% | +20.0% |
| Q3 2015 | $17,600,000 | -20.9% | 1,601,440 | -6.3% | 0.01% | 0.0% |
| Q2 2015 | $22,260,000 | -14.5% | 1,709,689 | +14.0% | 0.01% | -16.7% |
| Q1 2015 | $26,026,000 | +45.3% | 1,500,077 | +25.0% | 0.01% | +50.0% |
| Q4 2014 | $17,906,000 | +1.2% | 1,200,149 | +56.4% | 0.00% | -20.0% |
| Q3 2014 | $17,692,000 | -32.2% | 767,562 | -6.2% | 0.01% | -28.6% |
| Q2 2014 | $26,084,000 | – | 818,182 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |